You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 2, 2025

Drug Price Trends for NDC 23155-0071


✉ Email this page to a colleague

« Back to Dashboard


Best Wholesale Price for NDC 23155-0071

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug NameVendorNDCCountPrice ($)Price/Unit ($)DatesPrice Type
No data available in table
>Drug Name>Vendor>NDC>Count>Price ($)>Price/Unit ($)>Dates>Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies
Showing 0 to 0 of 0 entries

Market Analysis and Price Projections for Methimazole (NDC: 23155-0071)

Introduction to Methimazole

Methimazole, identified by the NDC code 23155-0071, is a medication used to treat hyperthyroidism, particularly in patients with Graves' disease or toxic multinodular goiter. It works by inhibiting the synthesis of thyroid hormones.

Current Market Scenario

Market Size and Growth

The global market for methimazole tablets has been valued significantly, with a projected compound annual growth rate (CAGR) indicating steady growth. This growth is driven by increasing demand for effective treatments for hyperthyroidism and the expanding patient population[1].

Pricing Trends

As of the latest data, the price per unit for methimazole 10 mg tablets, including the NDC code 23155-0071, is approximately $0.11178 per unit. This pricing is consistent across various vendors and distributors, indicating a stable market price[1].

Factors Influencing Pricing

Competition from Generics and Biosimilars

The life sciences industry is facing significant competition from generic drugs and biosimilars. For methimazole, being a generic medication itself, the competition is more about market share among different generic manufacturers. This competition can influence pricing strategies, as companies may adjust prices to remain competitive[3].

Regulatory and Transparency Requirements

Regulatory requirements, such as those outlined in the Prescription Drug Price Transparency Act, mandate pharmaceutical manufacturers to report price increases and other cost-related information. This transparency can impact pricing decisions, as manufacturers must justify price increases and be accountable for their pricing strategies[4].

Research and Development Costs

While methimazole is not a new drug, the overall R&D costs in the pharmaceutical industry can influence pricing. Manufacturers often factor in R&D expenses for new drugs and therapies, which can indirectly affect the pricing of existing medications[4].

Price Projections

Short-Term Projections

Given the current stable pricing and the absence of significant market disruptions, it is likely that the price of methimazole 10 mg tablets will remain relatively stable in the short term. The price per unit is expected to hover around $0.11 to $0.12 per unit[1].

Long-Term Projections

In the long term, several factors could influence pricing:

  • Generic Competition: As more generic versions of methimazole enter the market, prices may decrease due to increased competition.
  • Regulatory Changes: Changes in regulatory requirements or transparency laws could impact pricing strategies.
  • Market Demand: Changes in the prevalence of hyperthyroidism or advancements in treatment options could affect demand and subsequently prices[3][4].

Industry Trends and Outlook

Digital Transformation and Innovation

The life sciences industry is undergoing significant transformation driven by digital advancements and scientific innovations. While these trends are more relevant to new and innovative therapies, they can also impact the production and distribution of existing medications like methimazole. Improved operational efficiencies and new technologies could lead to cost savings that might be reflected in pricing[3].

Patent Cliff and Mergers & Acquisitions

Although methimazole is not directly affected by the patent cliff, the broader industry trends suggest that companies are looking to consolidate and innovate. This could lead to changes in market dynamics and pricing strategies as companies adjust to new market realities[3].

Key Takeaways

  • Current Pricing: The current price per unit for methimazole 10 mg tablets is approximately $0.11178.
  • Market Growth: The global market for methimazole tablets is expected to grow at a steady CAGR.
  • Regulatory Influence: Transparency laws and regulatory requirements can impact pricing strategies.
  • Long-Term Projections: Prices may remain stable or decrease slightly due to generic competition and regulatory changes.

FAQs

  1. What is the current price of methimazole 10 mg tablets? The current price per unit for methimazole 10 mg tablets is approximately $0.11178[1].

  2. What factors influence the pricing of methimazole? Factors include competition from generics, regulatory requirements, R&D costs, and market demand[3][4].

  3. Is the price of methimazole expected to change significantly in the short term? No, the price is expected to remain relatively stable in the short term[1].

  4. How does the life sciences industry's digital transformation affect methimazole pricing? While direct impacts are minimal, improved operational efficiencies from digital transformation could lead to cost savings that might be reflected in pricing[3].

  5. What are the long-term price projections for methimazole? Prices may remain stable or decrease slightly due to increased generic competition and regulatory changes[3][4].

Sources

  1. DrugPatentWatch - Drug prices and trends for METHIMAZOLE[1].
  2. San Mateo County Health - Shoppable services pricing[2].
  3. Deloitte Insights - 2025 life sciences outlook[3].
  4. Oregon Department of Consumer and Business Services - Prescription Drug Price Transparency Annual Report 2019[4].
  5. DailyMed - Label: METHIMAZOLE tablet[5].

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.